E-LIB Suche - Ergebnisse für: Ohira, Miki

1

A nationwide phase II study of delayed local treatment for ..:

Yoneda, Akihiro ; Shichino, Hiroyuki ; Hishiki, Tomoro...
Pediatric Blood & Cancer. 71 (2024) 6 - p. , 2024

Link: https://doi.org/10.1002/..

2

Polycomb group protein BMI1 protects neuroblastoma cells ag..:

Akita, Nobuhiro ; Okada, Ryu ; Mukae, Kyosuke...
Experimental Cell Research. 422 (2023) 1 - p. 113412 , 2023

Link: https://doi.org/10.1016/..

3

ATM depletion induces proteasomal degradation of FANCD2 and..:

Parvin, Sultana ; Akter, Jesmin ; Takenobu, Hisanori...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

4

Development of an osteosarcoma model with MYCN amplificatio..:

Mukae, Kyosuke ; Takenobu, Hisanori ; Endo, Yuki...
Cancer Science. 114 (2023) 5 - p. 1898-1911 , 2023

Link: https://doi.org/10.1111/..

5

The PRC2 molecule EED is a target of epigenetic therapy for..:

Shaliman, Dilibaerguli ; Takenobu, Hisanori ; Sugino, Ryuichi P...
European Journal of Cell Biology. 101 (2022) 3 - p. 151238 , 2022

Link: https://doi.org/10.1016/..

6

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivi..:

Shinno, Yoshitaka ; Takenobu, Hisanori ; Sugino, Ryuichi P....
Cancer Science. 113 (2022) 12 - p. 4193-4206 , 2022

Link: https://doi.org/10.1111/..

7

Comparative epigenomics by machine learning approach for ne..:

Sugino, Ryuichi P. ; Ohira, Miki ; Mansai, Sayaka P..
BMC Genomics. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

8

Retrospective Analysis of INRG Clinical and Genomic Factors..:

Ohira, Miki ; Nakamura, Yohko ; Takimoto, Tetsuya...
Biomolecules. 12 (2021) 1 - p. 18 , 2021

Link: https://doi.org/10.3390/..

9

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 c..:

Ando, Kiyohiro ; Ohira, Miki ; Takada, Ichiro...
Cancer Science. 113 (2021) 2 - p. 587-596 , 2021

Link: https://doi.org/10.1111/..

10

Loss of p53 suppresses replication stress-induced DNA damag..:

Akter, Jesmin ; Katai, Yutaka ; Sultana, Parvin...
Oncogenesis. 10 (2021) 11 - p. , 2021

Link: https://doi.org/10.1038/..

11

Correction to: Results of a phase II trial for high-risk ne..:

Hishiki, Tomoro ; Matsumoto, Kimikazu ; Ohira, Miki...
International Journal of Clinical Oncology. 25 (2020) 9 - p. 1744-1745 , 2020

Link: https://doi.org/10.1007/..

12

Targeting FROUNT with disulfiram suppresses macrophage accu..:

Terashima, Yuya ; Toda, Etsuko ; Itakura, Meiji...
Nature Communications. 11 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

13

TAp63 represses transcription of MYCN/NCYM gene and its hig..:

Suenaga, Yusuke ; Yamamoto, Mami ; Sakuma, Tetsushi...
Biochemical and Biophysical Research Communications. 518 (2019) 2 - p. 311-318 , 2019

Link: https://doi.org/10.1016/..

14

Results of a phase II trial for high-risk neuroblastoma tre..:

For the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) ; Hishiki, Tomoro ; Matsumoto, Kimikazu...
International Journal of Clinical Oncology. 23 (2018) 5 - p. 965-973 , 2018

Link: https://doi.org/10.1007/..

15

Genomic Amplifications and Distal 6q Loss: Novel Markers fo..:

Depuydt, Pauline ; Boeva, Valentina ; Hocking, Toby D...
JNCI: Journal of the National Cancer Institute. 110 (2018) 10 - p. 1084-1093 , 2018

Link: https://doi.org/10.1093/..